TITLE

Embryonic Stem cell research - The case against

AUTHOR(S)
Antoniou, Michael
PUB. DATE
April 2001
SOURCE
Nature Medicine;Apr2001, Vol. 7 Issue 4, p397
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Advocates against therapeutic use of and research on human embryonic stem (ES) cells. Practical issues associated with the cloning of ES cells; Safety involved in the usage of adult cells; Moral and ethical issues that needs to be addressed regarding therapeutic cloning of ES cells.
ACCESSION #
9511264

 

Related Articles

  • Putting stem cells to the test. Dolgin, Elie // Nature Medicine;Dec2010, Vol. 16 Issue 12, p1354 

    The article offers information on various types of tests conducted on stem cells. It mentions that the tests, such as teratoma assays, will prove if stem cells can produce new types of therapeutic tissues. However, some stem cell biologists doubt the capability of teratoma assay to determine the...

  • BIG idea MORE THAN TWO PARENTS. NEIMARK, JILL // Discover;Apr2013, Vol. 34 Issue 3, p12 

    The article examines how the creation of chimeric monkeys, offspring with more than two parents, can be used to study embryonic stem cell therapy. Information is provided on research from biologist Shoukhrat Mitalipov which found that using younger embryos made from totipotent stem cells was a...

  • Stem cell-based therapies in Parkinson's disease: future hope or current treatment option? Loewenbrück, Kai; Storch, Alexander // Journal of Neurology;May2011, Vol. 258 Issue 2, p346 

    Parkinson's disease (PD) is one of the most frequent neurodegenerative diseases and represents a major therapeutic challenge because of the so far missing therapeutic means to influence the ongoing loss of dopaminergic innervation to the striatum. Cell replacement has raised hope to offer the...

  • Research.  // Spectroscopy;Jun2008, Vol. 23 Issue 6, p13 

    The article reports on the potential of embryonic stem cell therapies to enhance cell differentiation. A new research work shows that the delivery of molecules within aggregates of embryonic stem cells through biodegradable microspheres enhances the efficiency and purity of differentiation. The...

  • Embryonic Stem Cells: Individual Medicine - But With 2 Individuals. Breindl, Anette // BioWorld Insight;5/20/2013, Vol. 21 Issue 21, p1 

    The article reports on the creation of embryonic stem cells by the researchers from the Oregon Health & Science University in Portland, Oregon using somatic cell nuclear transfer. It mentions that the researchers have pointed two individuals involved in generating the therapy, the patient and...

  • Human embryonic stem cells contaminated. Hampton, Tracy // JAMA: Journal of the American Medical Association;2/16/2005, Vol. 293 Issue 7, p789 

    Examines potential contamination of human embryonic stem cells (HESC) lines used in research. Findings of two California universities that HESC lines may not be suitable for therapeutic use in humans; Claim that the process of culturing HESC lines with animal-derived materials contaminates the...

  • Direct Reprogramming. Marbán, Eduardo; Cingolani, Eugenio // JAMA: Journal of the American Medical Association;7/7/2015, Vol. 314 Issue 1, p19 

    The authors comment on the direct reprogramming of stem cells for therapeutics. Topics covered include concerns that have restricted in vivo applications of tissues and organs to be recreated from embryonic stem cells, the limitations of induced stem cells as well as the complexity of...

  • Progress toward the clinical application of patient-specific pluripotent stem cells. Kiskinis, Evangelos; Eggan, Kevin // Journal of Clinical Investigation;Jan2010, Vol. 120 Issue 1, p51 

    Induced pluripotent stem (iPS) cells are generated by epigenetic reprogramming of somatic cells through the exogenous expression of transcription factors. These cells, just like embryonic stem cells, are likely to have a major impact on regenerative medicine, because they self-renew and retain...

  • What happened to the stem cells? Hviid Nielsen, T. // Journal of Medical Ethics;Dec2008, Vol. 34 Issue 12, p852 

    Five partly successive and partly overlapping framings have dominated the public debate about human embryonic stem cells since they first were "derived" a decade ago. Geron Corporation staged the initial framings as 1) basic research and 2) medical hope, but these two were immediately refuted...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics